From the Director’s Desk

The number 72 may not mean anything to some, but it does to the University of Illinois Cancer Center. Seventy of the more than 4,000 cancer centers in the United States are designated by the National Cancer Institute, with number 71 expected to be announced this summer. We are making great strides to become the 72nd such center. A top priority for UIC, as stated by Chancellor Michael Amiridis and university leadership, is…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following studies have recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112. A031701: A Phase II Study of Dose-Dense Gemcitabine Plus Cisplatin (ddGC) in Patients With Muscle-Invasive Bladder Cancer With Bladder Preservation for Those Patients…

Continue Reading